Physician profile
Rashmi Aggarwal
NPI 1912995820
$2,237.31
in general payments reported to CMS, 2019-2025
20 companies · $125 in 2025
The $125 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $244 · 2021: $396 · 2022: $250 · 2023: $174 · 2024: $498 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $360.00 | 2019-2022 | |
| Boston Scientific Corporation | $238.33 | 2019-2024 | Watchman Access System |
| Lilly USA, LLC | $138.43 | 2019-2024 | Jardiance |
| Ethicon INC. | $130.76 | 2023 | Monarch Platform |
| Amgen INC. | $125.00 | 2024 | Krystexxa |
| Ani Pharmaceuticals, INC. | $125.00 | 2025 | Purified Cortrophin Gel |
| Esperion Therapeutics, INC. | $125.00 | 2022 | |
| Alnylam Pharmaceuticals INC. | $125.00 | 2020 | |
| Vifor Pharma, INC. | $125.00 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $122.80 | 2024 | Inpefa |
| Inari Medical, INC. | $122.16 | 2021 | |
| Novartis Pharmaceuticals Corporation | $102.67 | 2019 | |
| Biosense Webster, INC. | $87.10 | 2020 | |
| Janssen Pharmaceuticals, INC | $78.49 | 2019 | |
| Ekos Corporation | $75.00 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $51.65 | 2019-2023 | |
| Glaxosmithkline, LLC. | $46.50 | 2019-2020 | |
| Pfizer INC. | $29.12 | 2023 | |
| Cranial Technologies, INC | $15.00 | 2019 | |
| Neos Therapeutics, LP | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashmi Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.